Nanozymes that mimic the catalytic reaction of natural
enzymes
show great prospects for tumor catalytic therapy because they possess
the properties of nanomaterials and natural enzymes. However, the
therapeutic effect of nanozymes is restricted by the low catalytic
efficiency and specific oxidation–reduction systems in the
tumor microenvironment (TME), such as overexpressed glutathione (GSH)
level. In order to improve the catalytic efficiency, a multifunctional
nanozyme, Cu/zeolitic imidazolate framework-67 (ZIF-67)/Prussian blue
(PB), was designed through the modification of Prussian blue (PB)
on the surface of the copper-doped zeolitic imidazolate framework,
which can be used for imaging-guided synergistic therapy with photothermal-enhanced
multienzyme-like catalytic therapy and chemotherapy. The doping of
Cu2+ provided better glutathione oxidase-like (GPx-like)
activity and peroxidase-like (POD-like) activity to deplete GSH and
increase the generation of •OH in TME. The modification
of PB provided better catalase-like activity (CAT-like) to promote
the production of O2 and enhance the multienzyme-like catalytic
therapy. In vivo experiments showed a satisfactory
anticancer effect. This work thus provided a strategy for designing
a type of multifunctional nanozyme for imaging-guided combination
therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.